Sort by:

select Language:

National Guidelines for Cholera Control

Dept. of Health, Republic of South Africa, (2014)

Guidelines for the treatment of malaria

World Health Organization, (2015)

3rd edition. The Guidelines include recommendations on the diagnosis and treatment of uncomplicated and severe malaria by all species, including in special at-risk populations (such as young children, pregnant women, TB or HIV/AIDS patients and non-immune travellers) and situations (such as epidemics and humanitarian emergencies), and on the use of drugs to prevent malaria in groups at high risk

Communicable diseases following natural disasters

World Health Organization, (2006)

Risk assessment and priority interventions

Management of a Measles Epidemic

Corinne Danet, and Florence Fermon, Eds.: Médecins Sans Frontières, (2013)

Practical guide for doctors, nurses, laboratory technicians, medical auxiliaries and logisticians

Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection

World Health Organization, (2015)

The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of nucleos(t)ide analogues with a high barrier to drug resistance (tenofovir and entecavir, and entecavir in children aged 2–11 years) for first- and second-line treatment. Recommendations for the treatment of HBV/HIV-coinfected persons are based on the WHO 2013 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, which will be updated in 2015.

Meningitis Outbreak Response in Sub-Saharan Africa

Christina Brandes-Barbier, Véronique Millot, Tomas Allen et al, Eds.: World Health Organization WHO, (2014)

WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are disappearing, but other serogroups (e.g. NmW, NmX and NmC) still cause epidemics, albeit at a lower frequency and of a smaller size. Due to these changes, WHO organized the review of the evidence to provide recommendations for epidemic control, related to operational thresholds for investigation and response to outbreaks, the use of rapid diagnostic tests, antibiotic regimens in epidemics, and prophylaxis for household contacts of cases

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Panel on Antiretroviral Guidelines for Adults and Adolescents, Eds.: Department of Health and Human Services, (2015)

Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.

134 hits